Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mol Cell ; 2(4): 417-25, 1998 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9809063

RESUMO

The pim-1 oncogene is regulated by hematopoietic cytokine receptors, encodes a serine/threonine protein kinase, and cooperates with c-myc in lymphoid cell transformation. Using a yeast two-hybrid screen, we found that Pim-1 protein binds to p100, a transcriptional coactivator that interacts with the c-Myb transcription factor. Pim-1 phosphorylated p100 in vitro, formed a stable complex with p100 in animal cells, and functioned downstream of Ras to stimulate c-Myb transcriptional activity in a p100-dependent manner. Thus, Pim-1 and p100 appear to be components of a novel signal transduction pathway affecting c-Myb activity, linking all three to the cytokine-regulated control of hematopoietic cell growth, differentiation, and apoptosis.


Assuntos
Acetiltransferases , Proteínas Nucleares/metabolismo , Proteínas Serina-Treonina Quinases/metabolismo , Proteínas Proto-Oncogênicas/metabolismo , Transdução de Sinais/fisiologia , Transativadores/metabolismo , Animais , Sequência de Bases , Células Cultivadas , Endonucleases , Regulação Enzimológica da Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Camundongos , Dados de Sequência Molecular , Proteínas Nucleares/genética , Regiões Promotoras Genéticas/fisiologia , Proteínas Serina-Treonina Quinases/genética , Proteínas/genética , Proteínas/metabolismo , Proteínas Proto-Oncogênicas/genética , Proteínas Proto-Oncogênicas c-myb , Proteínas Proto-Oncogênicas c-pim-1 , Transativadores/genética , Proteínas ras/metabolismo
2.
Endocrinology ; 138(8): 3521-31, 1997 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9231807

RESUMO

We have previously developed a transgenic (TG) mouse model expressing the Simian virus 40 T-antigen (Tag), driven by a 6-kb fragment of the mouse inhibin alpha-subunit promoter (inh-alpha). The mice develop metastasizing gonadal tumors, of granulosa/theca or Leydig cell origin, with 100% penetrance by the age of 5-8 months. In the present study, we examined whether the appearance and growth of the gonadal tumors are dependent on gonadotropins. Gonadotropin suppression was achieved either by treatment of 3-month-old mice for 2-3 months with a GnRH antagonist (Cetrorelix, SB-75), or by cross-breeding the TG mice to the genetic background of the gonadotropin-deficient hypogonadal mutant mouse (hpg). Gonadal tumor growth was clearly inhibited by SB-75 treatment in one of the TG mouse lines (IT6-M), as indicated by the absence of macroscopically visible tumors and by reduced gonadal weights. Despite the suppressed gonadotropin secretion and Tag expression, hyperplasia of testicular Leydig, and ovarian stromal cells persisted in some of the treated mice. In another TG mouse line (IT6-F), with more aggressive tumorigenesis, the SB-75 treatment only partially inhibited gonadal tumor growth. None of the hypogonadotropic TG mice, homozygous for the hpg mutation, developed gonadal tumors. Their gonadal histology was indistinguishable from that of the non-TG hpg mice, suggesting total inhibition of gonadal tumorigenesis in the absence of gonadotropin stimulation. Tag expression and Leydig cell hyperplasia were apparent already in the postnatal TG mice but absent in those TG mice homozygous for the hpg mutation. In conclusion, the present results indicate that the gonadal tumorigenesis in our TG mouse model starts in early age as hyperplasia in specific somatic cells. Both this, and the subsequent malignant tumor growth, are gonadotropin dependent. A sufficient level of Tag expression, a prerequisite for gonadal tumorigenesis, only occurs upon gonadotropin stimulation.


Assuntos
Antígenos Transformantes de Poliomavirus/genética , Transformação Celular Neoplásica/efeitos dos fármacos , Clonagem Molecular , Gonadotropinas/antagonistas & inibidores , Inibinas , Neoplasias Ovarianas/patologia , Peptídeos/genética , Neoplasias Testiculares/patologia , Animais , Antígenos Transformantes de Poliomavirus/análise , Modelos Animais de Doenças , Feminino , Hormônio Liberador de Gonadotropina/análogos & derivados , Hormônio Liberador de Gonadotropina/farmacologia , Gonadotropinas/metabolismo , Antagonistas de Hormônios/farmacologia , Hiperplasia , Células Intersticiais do Testículo/química , Células Intersticiais do Testículo/patologia , Masculino , Camundongos , Camundongos Transgênicos , Neoplasias Ovarianas/sangue , Neoplasias Ovarianas/genética , Ovário/patologia , Peptídeos/análise , Peptídeos/sangue , Hipófise/química , Progesterona/análise , Progesterona/sangue , Regiões Promotoras Genéticas/genética , RNA Mensageiro/análise , RNA Mensageiro/genética , Neoplasias Testiculares/sangue , Neoplasias Testiculares/genética , Testículo/patologia , Testosterona/análise , Testosterona/sangue , Fatores de Tempo
3.
Mol Endocrinol ; 10(12): 1667-77, 1996 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8961275

RESUMO

We have developed a transgenic (TG) mouse model for gonadal tumorigenesis expressing the Simian virus 40 T-antigen (Tag) under the mouse inhibin alpha-subunit promoter. Gonadal tumors appear with 100% penetrance by the age of 5-8 months in the TG mice. When 1-month-old TG mice were gonadectomized, adrenal gland tumors were observed in each animal (12 females, 11 males) at the age of 6-8 months. No adrenal tumors were detected in gonadectomized non-TG mice (nine females, nine males) or in the intact TG mice (n > 100). The tumors appeared to originate from the X zone of the adrenal cortex. The TG mice with adrenocortical tumors had elevated serum levels of progesterone, estradiol, and immunoreactive inhibin (including dimeric forms), but corticosterone secretion was reduced. The lack of adrenal tumors in intact TG mice suggested that the tumorous gonads secrete factor(s) inhibiting adrenal tumorigenesis. As a candidate molecule, we studied the effects of inhibin, which was high in the serum of control females and TG females with ovarian tumors, as well as in TG males with testicular tumors. The DNA synthesis, as well as the levels of inhibin-alpha and Tag mRNA expression, were significantly reduced by recombinant human inhibin A in cell cultures derived from the adrenal tumors. In accordance, the expression level of inhibin-alpha mRNA in the normal adrenal gland was elevated 2 weeks after gonadectomy. These findings suggest that gonadal inhibin can down-regulate the expression of the inhibin alpha-subunit gene in the adrenal gland. When circulating inhibin is eliminated by gonadectomy, Tag expression and tumorigenesis are stimulated in the adrenal glands of the TG mice. The results demonstrate a novel mechanism of autoregulation in inhibin alpha-subunit gene expression.


Assuntos
Neoplasias do Córtex Suprarrenal/genética , Antígenos Transformantes de Poliomavirus/genética , Homeostase/genética , Camundongos Transgênicos/genética , Peptídeos/genética , Ativinas , Neoplasias do Córtex Suprarrenal/patologia , Neoplasias do Córtex Suprarrenal/secundário , Animais , Antígenos Transformantes de Poliomavirus/imunologia , Antígenos Transformantes de Poliomavirus/metabolismo , Castração , Divisão Celular/efeitos dos fármacos , Modelos Animais de Doenças , Estradiol/sangue , Feminino , Imuno-Histoquímica , Inibinas/farmacologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos DBA , Peptídeos/sangue , Peptídeos/farmacologia , Progesterona/sangue , Regiões Promotoras Genéticas , Proteínas Recombinantes de Fusão/genética , Células Tumorais Cultivadas
4.
Mol Endocrinol ; 9(5): 616-27, 1995 May.
Artigo em Inglês | MEDLINE | ID: mdl-7565808

RESUMO

To establish in vivo gonadal tumor models and permanent lines of gonadal somatic cells we produced transgenic (TG) mice expressing the Simian virus (SV) 40 T-antigens (T-ag), driven by 6 or 2.1 kilobase fragments of the mouse inhibin alpha-subunit promoter. Hitherto, altogether 44 TG mice, one of which carried the shorter transgene, have produced gonadal tumors. Two founder females expressing the longer transgene, KK1 and KK3, and three established TG mouse lines were studied in detail. Penetrance of the phenotype in IT6-M and IT6-F mouse lines was 100% (tumors/TG: IT6-M 22/22, IT6-F 14/14). The T-ag mRNA was strongly expressed in the gonads, adrenal glands, pituitary, and brain. The KK-1 and KK-3 ovarian tumor cells immunostained with anti-SV40 large-T antibody. The KK-1 cells possessed high-affinity LH receptors [equilibrium association constant (Ka = 7.8 x 10(10) liters/mol] and responded to human CG by elevated cAMP and progesterone production. Also FSH slightly stimulated their cAMP and estradiol production (P < 0.01). These cells expressed cytochrome P450arom and inhibin alpha mRNA, but not cytochrome P450c17 alpha. In conclusion, the KK-1 cells are immortalized luteinizing granulosa cells expressing endogenous gonadotropin receptors, steroidogenic enzymes, and inhibin alpha. These cells will be useful in studies on the molecular aspects of granulosa cell function. The present study indicates that the 6-kilobase fragment of the inhibin alpha promoter described in this article contains the elements directing tissue-specific expression in vivo and is useful for targeted expression of other genes in the gonads.


Assuntos
Gonadotropinas/farmacologia , Células da Granulosa/citologia , Células da Granulosa/efeitos dos fármacos , Inibinas/genética , Camundongos Transgênicos , Neoplasias Ovarianas/patologia , Vírus 40 dos Símios/genética , Ativinas , Animais , Antígenos Transformantes de Poliomavirus , Sequência de Bases , Divisão Celular/efeitos dos fármacos , Linhagem Celular , AMP Cíclico/metabolismo , Modelos Animais de Doenças , Feminino , Expressão Gênica , Inibinas/farmacologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos DBA , Dados de Sequência Molecular , Neoplasias Experimentais , Neoplasias Ovarianas/fisiopatologia , Regiões Promotoras Genéticas/fisiologia , RNA Mensageiro , Receptores do LH/genética , Vírus 40 dos Símios/imunologia , Esteroides/metabolismo , Proteínas Virais de Fusão/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...